These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10609092)

  • 1. Obesity drugs and the heart.
    Connolly HM; McGoon MD
    Curr Probl Cardiol; 1999 Dec; 24(12):745-92. PubMed ID: 10609092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appetite suppressants and valvular heart disease.
    Seghatol FF; Rigolin VH
    Curr Opin Cardiol; 2002 Sep; 17(5):486-92. PubMed ID: 12357124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anorexigen-related cardiopulmonary toxicity.
    Gross SB; Lepor NE
    Rev Cardiovasc Med; 2000; 1(2):80-9, 102. PubMed ID: 12457145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine].
    Wolf I; Mouallem M; Farfel Z
    Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468
    [No Abstract]   [Full Text] [Related]  

  • 5. Further cases of valvular heart disease associated with fenfluramine-phentermine.
    Graham DJ; Green L
    N Engl J Med; 1997 Aug; 337(9):635. PubMed ID: 9280830
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
    Goldstein SE; Levy Y; Shoenfeld Y
    Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appetite-suppressant drugs and valvular heart disease.
    Shapiro S
    N Engl J Med; 1999 Feb; 340(6):477-8; author reply 478-80. PubMed ID: 9988622
    [No Abstract]   [Full Text] [Related]  

  • 8. Heart valve disorders and appetite-suppressant drugs.
    Jick H
    JAMA; 2000 Apr; 283(13):1738-40. PubMed ID: 10755501
    [No Abstract]   [Full Text] [Related]  

  • 9. Valvular heart disease associated with fenfluramine-phentermine.
    Spitzer WO
    N Engl J Med; 1997 Dec; 337(24):1774-5; author reply 1775-6. PubMed ID: 9411251
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pulmonary hypertension and heart valve diseases induced by fenfluramine? Hypothesis or certitude? Myth or reality?].
    Godeau P; Cherin P; Tellier P
    Rev Med Interne; 1998 Oct; 19(10):700-3. PubMed ID: 9827440
    [No Abstract]   [Full Text] [Related]  

  • 11. Diet pills redux.
    Curfman GD
    N Engl J Med; 1997 Aug; 337(9):629-30. PubMed ID: 9271487
    [No Abstract]   [Full Text] [Related]  

  • 12. Valvular heart disease associated with fenfluramine-phentermine.
    Connolly HM; Crary JL; McGoon MD; Hensrud DD; Edwards BS; Edwards WD; Schaff HV
    N Engl J Med; 1997 Aug; 337(9):581-8. PubMed ID: 9271479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Appetite suppressants and heart valve disorders].
    Adams C; Cohen A
    Arch Mal Coeur Vaiss; 1999 Sep; 92(9):1213-9. PubMed ID: 10533670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.
    Gardin JM; Weissman NJ; Leung C; Panza JA; Fernicola D; Davis KD; Constantine GD; Reid CL
    JAMA; 2001 Oct 24-31; 286(16):2011-4. PubMed ID: 11667938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fen-phen's message to dentists.
    Hilsen K; Davis S; Iyer P
    J N J Dent Assoc; 1998; 69(1):37, 47. PubMed ID: 9584764
    [No Abstract]   [Full Text] [Related]  

  • 16. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.
    Gardin JM; Schumacher D; Constantine G; Davis KD; Leung C; Reid CL
    JAMA; 2000 Apr; 283(13):1703-9. PubMed ID: 10755496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminorex to Fen/Phen: an epidemic foretold.
    Tellier P
    Circulation; 1999 Dec; 100(25):e146; author reply e147. PubMed ID: 10604912
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of obesity with drugs.
    Hirsch J
    Am J Clin Nutr; 1998 Jan; 67(1):2-4. PubMed ID: 9440366
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe heart valve disease on appetite suppressants.
    Prescrire Int; 1998 Feb; 7(33):19-20. PubMed ID: 10183395
    [No Abstract]   [Full Text] [Related]  

  • 20. Appetite suppressants and cardiac valvulopathy. Current clinical perspectives.
    Gross SB
    Adv Nurse Pract; 1999 Oct; 7(10):36-40. PubMed ID: 10808770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.